FDA orders new warning labels on Ozempic, Wegovy over rare risk of permanent vision loss
The Food and Drug Administration now requires warning labels on Ozempic, Wegovy and other GLP-1 drugs over a rare eye condition tied to vision loss.
Full story
Read the full story at Fox Business ↗
Continue reading this story on Fox Business, the publisher that reported it.
AI tools
Written by AI from the article text. It can make mistakes; check the original story.
